Education

Personal Finance How To Use TipRanks TipRanks Labs Webinar Center Glossary FAQs

About Us

About TipRanks Contact Us Careers Reviews Mobile APP

Working with TipRanks

Enterprise Solutions Advertise with Us Top Online Brokers Become an Affiliate

News Trending Portfolio

TOOLS

Top Smart Score Stocks

STOCKS

Best High Yield Dividend Stocks

Dividend Aristocrats

Dividend Stock Comparison

New

Dividend Calculator

Dividend Returns Comparison

Dividend Calendar

Top Analysts

Top Financial Bloggers

Top-Performing Corporate Insiders

Top Hedge Fund Managers

Top Research Firms

Top Individual Investors

News

Portfolio

Personal Finance Center

Mortgages

Loans

Investing & Retirement

Spending & Savings

Calculators

Compound Interest Calculator

Student Loan Calculator

401k Retirement Calculator

Education

About Us

Working with TipRanks

Enterprise Solutions

Top Online Brokers

Become an Affiliate

Pharma Mar SA (ES:PHM)

BME:PHM

PHM

Pharma Mar SA

RESEARCH TOOLS

Top Smart Score Stocks

Stock Screener

reports

Holding ES:PHM?

Track your performance easily

Link Broker

Pharma Mar SA (PHM) Income Statement

11 Followers

Pharma Mar SA Income Statement

Last quarter (Q4 2022), Pharma Mar SA's total revenue was C$54.94M, an increase of Infinity% from the same quarter last year. In Q4, Pharma Mar SA's net income was C$5.98M. See Pharma Mar SA’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 22	Dec 21	Dec 20	Dec 19	Dec 18
Total Revenue	C$ 54.94M	C$ 196.34M	-	-	C$ 85.82M	C$ 108.77M
Cost of Revenue	C$ 6.23M	C$ 13.64M	C$ 76.74K	-	C$ 5.23M	C$ 4.92M
Gross Profit	C$ 48.71M	C$ 182.70M	C$ -76.74K	-	C$ 80.59M	C$ 103.85M
Operating Expense	C$ 45.54M	C$ 138.27M	C$ 759.43K	-	C$ 98.07M	C$ 119.87M
Operating Income	C$ 3.18M	C$ 44.44M	C$ -836.17K	-	C$ -17.48M	C$ -16.03M
Net Non Operating Interest Income Expense	C$ -7.41M	C$ -1.50M	-	-	C$ -3.85M	C$ -4.11M
Other Income Expense	-	-	C$ -1.49M	-	-	-
Pretax Income	C$ -2.82M	C$ 43.79M	C$ -2.32M	-	C$ -21.65M	C$ -19.99M
Tax Provision	C$ -4.21M	C$ -5.57M	-	-	C$ -12.47M	C$ -2.88M
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	C$ 5.98M	C$ 49.36M	C$ -2.32M	-	C$ -11.38M	C$ -5.54M
Basic EPS	-	-	-	-	C$ -0.60	C$ -0.36
Diluted EPS	-	-	-	-	C$ -0.60	C$ -0.36
Basic Average Shares	-	-	-	-	C$ 18.44M	C$ 18.41M
Diluted Average Shares	-	-	-	-	C$ 18.44M	C$ 18.41M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	C$ 51.77M	C$ 151.91M	C$ -836.17K	-	C$ 103.29M	C$ 124.80M
Interest Expense	-	C$ 2.38M	-	-	C$ 3.89M	C$ 4.14M
Net Income From Continuing And Discontinued Operation	C$ 5.98M	C$ 49.36M	C$ -2.32M	-	C$ -11.38M	C$ -5.54M
Normalized Income	C$ 169.51K	C$ 50.71M	C$ -2.32M	-	C$ -8.96M	C$ -17.15M
EBIT	C$ 2.67M	C$ 46.17M	C$ -2.32M	-	C$ -17.77M	C$ -15.85M
EBITDA	C$ 6.97M	C$ 52.07M	-	-	C$ -9.73M	C$ -9.47M

Currency in CAD

Pharma Mar SA Earnings and Revenue History

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing